Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website


Immunogen reported $92.26M in Operating Expenses for its fiscal quarter ending in March of 2023.

Operating Expenses Change
AbbVie ABBV:US USD 9.46B 162M
Agios Pharmaceuticals AGIO:US USD 96.22M 120.59M
Amgen AMGN:US USD 4.07B 538M
Astellas Pharma 4503:JP JPY 402.5B 61.71B
AstraZeneca AZN:LN USD 8.33B 1.78B
Bluebird Bio BLUE:US USD -6056000 19.32M
Bristol-Myers Squibb BMY:US USD 8.24B 1.22B
Eli Lilly LLY:US USD 5.47B 600K
Emergent BioSolutions EBS:US USD 313.2M 82.6M
Exelixis EXEL:US USD 379.96M 92.04M
Halozyme Therapeutics HALO:US USD 108.34M 1.35M
Heron Therapeutics HRTX:US USD 62.68M 12.3M
Immunogen IMGN:US USD 92.26M 8.46M
Intrexon XON:US USD 25.33M 1.77M
Karyopharm Therapeutics KPTI:US USD 69.6M 2.15M
MacroGenics MGNX:US USD 62.92M 1.81M
Nektar Therapeutics NKTR:US USD 156.3M 81.81M
Novartis NVS:US USD 10.35B 700M
Pfizer PFE:US USD 11.5B 7.63B
Regeneron Pharmaceuticals REGN:US USD 2.22B 52.2M
Roche Holding ROG:VX 25.06B 4.31B
Seattle Genetics SGEN:US USD 704.23M 22.08M